333 related articles for article (PubMed ID: 31585768)
21. Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.
Thoonen R; Ernande L; Cheng J; Nagasaka Y; Yao V; Miranda-Bezerra A; Chen C; Chao W; Panagia M; Sosnovik DE; Puppala D; Armoundas AA; Hindle A; Bloch KD; Buys ES; Scherrer-Crosbie M
J Mol Cell Cardiol; 2015 Jul; 84():202-11. PubMed ID: 25968336
[TBL] [Abstract][Full Text] [Related]
22. Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.
Falase AO; Ogah OS
Cardiovasc J Afr; 2012 Nov; 23(10):552-62. PubMed ID: 23192260
[TBL] [Abstract][Full Text] [Related]
23. Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy.
Roberts JD; Veinot JP; Rutberg J; Gollob MH
Cardiovasc Pathol; 2010; 19(5):316-20. PubMed ID: 19632136
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis.
Won S; Davies-Venn C; Liu S; Bluemke DA
Curr Opin Cardiol; 2013 May; 28(3):282-9. PubMed ID: 23549230
[TBL] [Abstract][Full Text] [Related]
25. Regulation of cardiac fibroblasts by lymphocytes after a myocardial infarction: playing in the major league.
Learmonth M; Corker A; Dasgupta S; DeLeon-Pennell KY
Am J Physiol Heart Circ Physiol; 2023 Sep; 325(3):H553-H561. PubMed ID: 37450290
[TBL] [Abstract][Full Text] [Related]
26. Pediatric Cardiomyopathies.
Lee TM; Hsu DT; Kantor P; Towbin JA; Ware SM; Colan SD; Chung WK; Jefferies JL; Rossano JW; Castleberry CD; Addonizio LJ; Lal AK; Lamour JM; Miller EM; Thrush PT; Czachor JD; Razoky H; Hill A; Lipshultz SE
Circ Res; 2017 Sep; 121(7):855-873. PubMed ID: 28912187
[TBL] [Abstract][Full Text] [Related]
27. Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
Bansal SS; Ismahil MA; Goel M; Zhou G; Rokosh G; Hamid T; Prabhu SD
Circulation; 2019 Jan; 139(2):206-221. PubMed ID: 30586716
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
[TBL] [Abstract][Full Text] [Related]
29. Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.
Callis TE; Jensen BC; Weck KE; Willis MS
Expert Rev Mol Diagn; 2010 Apr; 10(3):329-51. PubMed ID: 20370590
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.
Podlesnikar T; Delgado V; Bax JJ
Int J Cardiovasc Imaging; 2018 Jan; 34(1):97-112. PubMed ID: 28642994
[TBL] [Abstract][Full Text] [Related]
31. Clinical aspects of hypertensive myocardial fibrosis.
Díez J; López B; González A; Querejeta R
Curr Opin Cardiol; 2001 Nov; 16(6):328-35. PubMed ID: 11704701
[TBL] [Abstract][Full Text] [Related]
32. Sex-Related Differences in Genetic Cardiomyopathies.
Argirò A; Ho C; Day SM; van der Velden J; Cerbai E; Saberi S; Tardiff JC; Lakdawala NK; Olivotto I
J Am Heart Assoc; 2022 May; 11(9):e024947. PubMed ID: 35470690
[TBL] [Abstract][Full Text] [Related]
33. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy.
Henkel DM; Glockner J; Miller WL
Am J Cardiol; 2012 Feb; 109(3):390-4. PubMed ID: 22078219
[TBL] [Abstract][Full Text] [Related]
34. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
35. Relation of Myocardial Contrast-Enhanced T
Höke U; Khidir MJ; van der Geest RJ; Schalij MJ; Bax JJ; Delgado V; Ajmone Marsan N
Am J Cardiol; 2017 May; 119(9):1456-1462. PubMed ID: 28274575
[TBL] [Abstract][Full Text] [Related]
36. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy, cardiomyopathies, and genetics.
Van Tintelen JP; Pieper PG; Van Spaendonck-Zwarts KY; Van Den Berg MP
Cardiovasc Res; 2014 Mar; 101(4):571-8. PubMed ID: 24451172
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance.
Arimura T; Muchir A; Kuwahara M; Morimoto S; Ishikawa T; Du CK; Zhan DY; Nakao S; Machida N; Tanaka R; Yamane Y; Hayashi T; Kimura A
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1192-H1202. PubMed ID: 29451818
[TBL] [Abstract][Full Text] [Related]
39. The pathobiology of arrhythmogenic cardiomyopathy.
Saffitz JE
Annu Rev Pathol; 2011; 6():299-321. PubMed ID: 21073337
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers of myocardial fibrosis.
de Jong S; van Veen TA; de Bakker JM; Vos MA; van Rijen HV
J Cardiovasc Pharmacol; 2011 May; 57(5):522-35. PubMed ID: 21423029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
